Top Markets
Coin of the day
SpyGlass Pharma, Inc. Common Stock SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
Rank in Stocks #10213
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Share Price
$26.13
Last synced: 2026-08-28
Market Cap
$873.45M
Change (1 day)
-2.99%
Change (1 year)
-
Country
US
Trade SpyGlass Pharma, Inc. Common Stock (SGP)

Category

P/B ratio for SpyGlass Pharma, Inc. Common Stock (SGP)
P/B ratio as of 2026 TTM: 0
According to SpyGlass Pharma, Inc. Common Stock latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for SpyGlass Pharma, Inc. Common Stock from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH